A
Approxima
The first minimally invasive treatment tailored for the tricuspid valve
About Approxima
Approxima Medical is a forward-thinking company specializing in the development of advanced medical technologies aimed at improving patient care and treatment outcomes. Focused on precision and innovation, Approxima Medical integrates cutting-edge technology with clinical expertise to create solutions that address complex medical challenges.
Read full description
Their offerings include a range of sophisticated devices and systems designed to enhance diagnostic accuracy, streamline treatment processes, and support healthcare professionals in delivering optimal care. By leveraging state-of-the-art technology and a deep understanding of clinical needs, Approxima Medical aims to transform the landscape of modern medicine.
Committed to advancing healthcare, Approxima Medical emphasizes research and development to bring groundbreaking solutions to market. Their products are crafted to meet the highest standards of quality and performance, ensuring that they provide significant benefits to both patients and healthcare providers.
Through their innovative approach, Approxima Medical is dedicated to making a meaningful impact on patient health and the efficiency of healthcare systems, striving to deliver technologies that improve outcomes and elevate the standard of care.
At a glance
- Status
- Operational
- Founded
- 2020
- Headquarters
- Milan, Italy
- Employees
- 18
- Open positions
- None listed
- Dealroom signal
- 74.3/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, medical implants, Surgery, Cardiology and cardiovascular, Patient Care, Spinout, Innostars Awards (EIT Health), Innostars Awards 2020 (EIT Health), EIT Health, Hard Tech
- Technology
- Deep Tech, Connected Device
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | Mar 2026 | $9.7M | $39M | Aegis Capital · Panakès Partners · Fondazione ENEA Tech | ↗ |
| SERIES A✓Equity / VC | Feb 2025 | $8M | $32M | Panakès Partners · Fondazione ENEA Tech | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Approxima is 20 monthly website visits, down 60% over the last three months. Approxima's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed2 investors entered at this stage
Panakès Partners
Investors' club
Series A2 investors entered at this stage
Fondazione ENEA Tech
Aegis Capital
Other known investors2 additional known investors
EIT Health
Polytechnic University of Milan
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Approxima on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Approxima’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.